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Abstract
Background: Cerebrotendinous xanthomatosis is a rare autosomal recessive neurometabolic disorder characterized by chronic diarrhea, tendon xanthomas,
juvenile cataracts, and neurological symptoms.
Case Report: An adult patient with cerebrotendinous xanthomatosis exhibited ataxia and palatal tremor in the absence of tendon xanthomas and cataracts.
Discussion: The importance of this case resides on the fact that cerebrotendinous xanthomatosis should be considered as a possible etiology of the syndrome of
progressive ataxia with palatal tremor, even in the absence of tendon xanthomas and cataracts. Early diagnosis is critical to the institution of specific treatment with
chenodeoxycholic acid.
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Introduction
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive
neurometabolic disorder characterized by infantile or early childhood
onset of chronic diarrhea, tendon xanthomas, cataracts, and neurological
problems, such as behavioral disorders, cognitive impairment, peripheral
neuropathy, dystonia, parkinsonism, epilepsy, myoclonus, and progres-
sive cerebellar ataxia, that usually start in the second or third decades of
life.1,2 This disease is caused by mutations in the CYP27A1 gene that
result in decreased production of chenodeoxycholic acid and elevated
levels of cholestanol and bile alcohols.3 Chenodeoxycholic acid is an
established treatment that restores metabolic abnormalities and may
improve or even prevent neurological deterioration,4 especially if it is
instituted at the early stages of the disease process.5
Case report
A 31-year-old female with no family history of neurological disease
or consanguinity was evaluated after a 4-year history of gait instability,
dysarthria, and dysphagia. She had a relevant history of chronic diarrhea
at early childhood and depression since 20 years of age. Physical
examination disclosed spasmodic-like dysphonia, altered saccadic eye
movements, pyramidal signs, proximal and distal muscle wasting in the
upper and lower limbs, palatal tremor at low frequency without ear or
throat clicks, and mild limb and gait ataxia (Video 1). The Scale for the
Assessment and Rating of Ataxia (SARA) score was 15. No tendon
xanthomas were present (Figure 1). Electromyography and a nerve
conduction study revealed a sensorimotor axonal polyneuropathy. Brain
magnetic resonance imaging (MRI) displayed mild cerebellar atrophy
and bilateral hyperintensity of the dentate nuclei on fluid-attenuated
inversion recovery and T2-weighted images, with a central hypointensity
suggestive of calcification (Figure 2A, left and central) and bilateral
hyperintensity of the basal ganglia (Figure 2A, right). The olivary nuclei
showed a serpiginous abnormal signal, although there was no classic
olivary hypertrophy (Figure 2B, left). A brain computed tomography scan
showed subtle calcifications in the white matter surrounding the dentate
nucleus (Figure 2B, right). Routine work-up studies for ataxia, such
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as alpha-fetoprotein, thyroid function and anti-thyroid peroxidase
antibodies, celiac disease antibodies (transglutaminase, anti-gliadin, and
anti-endomysial), anti-neuronal antibodies, ceruloplasmin, human immu-
nodeficiency virus, cupruria, vitamin B1, B12, and vitamin E levels were
normal or negative, except for plasmatic cholesterol levels, which were
low (111 mg/dL). CAG repeat determination in the ATXN1, ATXN2,
ATXN3, CACNA1A, and ATXN7 genes were negative. Whole-exome seq-
uencing detected two heterozygous variants (c.1183C.T p.(Arg395Cys)
and c.1184+1G.A) in the trans-phase in the CYP27A1 gene consistent
with a diagnosis of CTX. Cholestanol levels in the serum and tendons
were not available for evaluation in our patient. Treatment with
chenodeoxycholic acid was started, with improvement of irritability and
gait instability (SARA scores slightly improved from 15 to 14 points
because of a change in the item that measures stance) and weight gain.
Discussion
This patient with CTX exhibited palatal tremor and progressive
ataxia as the most prominent clinical signs, but without tendon
xanthomas and juvenile cataracts, which are clinical hallmarks of
CTX. The frequency of juvenile cataracts and tendon xanthomas in
CTX patients averages 88% and 78%, respectively.6 We cannot rule
out the possibility that both problems can appear later in the course
of the disease. However, this possibility would be very low, as appro-
ximately 75% of CTX patients present with cataracts, often appearing
in the first decade of life, whereas xanthomas commonly develop in the
second or third decade.6,7 Large deposits of cholesterol and choles-
tanol, the 5-alpha-dihydro derivative of cholesterol, are found in
virtually every tissue, particularly the Achilles tendons.7 Low choles-
terol and high cholestanol levels in the serum and tendons support the
diagnosis of this entity, besides genetic testing.3,7 Reports of palatal
tremor (also referred previously as palatal myoclonus) in genetically
confirmed patients with CTX are rare.8,9 This atypical case combines
palatal tremor and ataxia in the absence of the most characteristic
clinical features of CTX, thus highlighting the phenotypic variability of
this genetic entity. The syndrome of familial or sporadic progressive
ataxia and palatal tremor (PAPT) is rare in clinical practice and the
cause usually remains uncertain.10,11 In the sporadic form, brain MRI
frequently shows hyperintensity in the inferior olivary nuclei.10 Even
though no classic olivary hypertrophy was found in the patient
described here, the olivary nuclei contained a serpiginous abnormal
signal suggestive of a ‘‘forme fruste’’ or variant of olivary hypertrophic
degeneration. Also, olivary hypertrophy may not be evident with
routine MRI sequences, and its presence depends on the stage of
olivary degeneration.12 Despite the subtle olivary nuclei abnormalities,
the clinical picture may exceed the classical PAPT syndrome.
A number of differential diagnoses must be considered in patients
with progressive ataxia and palatal tremor. For example, the combi-
nation of ataxia, palatal tremor, dysphonia resembling spasmodic
dysphonia, and dentate calcifications may orient to spinocerebellar
ataxia type 20.13 The hyperintensities observed in the dentate nucleus
and the surrounding white matter are common features reported in
CTX.14 Other entities that present with progressive ataxia and palatal
Figure 1. Imaging of both feet. Atrophy of the distal foot muscles and absence of xanthomas in the Achilles tendons. There were also no xanthomas in other body parts.
Video 1. Cerebrotendinous xanthomatosis revealed by ataxia and
palatal tremor in the absence of tendon xanthomas and cataracts.
A 30-year-old female with genetically confirmed cerebrotendinous
xanthomatosis showing mild limb and gait ataxia (Segment 1A and 1B)
and palatal tremor at low frequency (Segment 1C).
Rossi M, Cesarini M, Gatto EM, et al. Palatal Tremor and Ataxia in Cerebrotendinous Xanthomatosis
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org Columbia University Libraries2
Figure 2. Brain Magnetic Resonance Imaging. (A) Flair and T2-weighted images display mild cerebellar atrophy and bilateral hyperintensity of the dentate
nuclei on Flair and T2-weighted images with a central hypointensity suggestive of calcification (left and central). Bilateral hyperintensity of the basal ganglia (right).
(B) Olivary nuclei with a serpingous abnormal signal (left). Subtle calcifications in the white matter surrounding the dentate nucleus (right).
Table 1. Differential Diagnosis of Progressive Ataxia and Palatal Tremor
Disease Name (Gene) Inheritance Main Clinical Features Besides




AD Dysphonia resembling spasmodic dysphonia,




Spastic paraplegia type 7
or HSP/ATX-SPG7
(SPG7)18
AR/AD Spastic paraparesis, optic atrophy, nystagmus,
chronic external ophthalmoplegia-like
phenotype, pes cavus, decreased vibratory sense
in the lower limbs, scoliosis




AD Chorea, oromandibular dyskinesia, dystonia,
parkinsonism, dysphagia, psychiatric
symptoms, cognitive impairment
Iron accumulation in globus pallidus,
caudate, putamen, substantia nigra, red
nucleus; cystic basal ganglia changes and
pallidal necrosis
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tremor are listed in Table 1. A functional disruption in the ‘‘Mollaret’s
triangle’’, formed by the red, dentate, and inferior olivary nuclei has
been postulated as the cause of palatal tremor.15 Presumably, in this
patient, the palatal tremor arose because of a disruption of the denta-
torubroolivary circuit secondary to the lesions in the olivary nuclei and
dentate nuclei.
Neurologists should consider CTX when ataxia, palatal tremor,
and dentate nuclei hyperintensities are present, even in the absence of
tendon xanthomas and cataracts. Patients with progressive ataxia and
palatal tremor should be exhaustively studied, because some cases,
as the one described here, are not sporadic, but of genetic origin and
also susceptible to specific treatment.16 CTX should be added to the
differential diagnosis of progressive ataxia and palatal tremor.
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